citadel gsk - Search News

GSK shares shorted by leading U.S. hedge fund, Times reports

Hedge fund Citadel takes short position in GSK, FT reports

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times reported on Friday.

Investing.com on MSN · 17h

Citadel takes $384.5 million short position in GSK - FT

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British pharmaceutical company. The Financial Times reported this on Friday that Citadel's short position is valued at 305 million pounds ($384.

Markets Insider · 21h

GSK shares shorted by leading U.S. hedge fund, The Times reports

The world’s most profitable hedge fund has started betting against shares in GSK (GSK), the first significant short on the FTSE 100 drugmaker’s

21h

Ken Griffin’s Citadel bets £300mn against drugmaker GSK

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Devdiscourse16h

Health News Update: Moderna Vaccine Halted, GSK Shorted, Bird Flu Response Disrupted and More

Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...

17h

PRESS: Ken Griffin's Citadel bets GBP300 million against GSK - FT

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

GSK shares shorted by leading U.S. hedge fund, Times reports

Trending now